Fibronectin based scaffold domain proteins that bind to myostatin

US8933199B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8933199-B2
Application numberUS-201314025253-A
CountryUS
Kind codeB2
Filing dateSep 12, 2013
Priority dateSep 13, 2012
Publication dateJan 13, 2015
Grant dateJan 13, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

First claim

Opening claim text (preview).

We claim: 1. A polypeptide comprising a fibronectin type III tenth ( 10 Fn3) domain which binds to myostatin and comprises the amino acid sequence of SEQ ID NO: 6, wherein (Z) x , (Z) y and (Z) z comprise: (a) the amino acid sequences of SEQ ID NOs: 7, 39 and 46, respectively (b) the amino acid sequences of SEQ ID NOs: 8, 40 and 47, respectively; (c) the amino acid sequences of SEQ ID NOs: 12, 42 and 51, respectively; (d) the amino acid sequences of SEQ ID NOs: 17, 39 and…

Assignees

Inventors

Classifications

  • Human Necessities · mapped topic

  • Human Necessities · mapped topic

  • Human Necessities · mapped topic

  • Human Necessities · mapped topic

  • Human Necessities · mapped topic

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8933199B2 cover?
The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates t…
Who is the assignee on this patent?
Bristol Myers Squibb Co
What technology area does this patent fall under?
Primary CPC classification C07K14/78. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).